Beneficial Ownership Report

FATE THERAPEUTICS INC Filed 2023-04-19 Acc 0001104659-23-047252

Documents 1

2023-12-28 SC 13D/A Beneficial Ownership Report
2023-04-19 4 Chief Medical Officer sold 2,532 shares at an average $6.57 ($16,648)
2023-04-19 SC 13D/A Beneficial Ownership Report
2023-04-19 8-K Delisting notice · Bylaws or fiscal year change
2023-04-18 144 Sale of Securities
2023-04-17 4 Director sold 302,339 shares at $5.84 ($1,765,660)
2021-01-12 SC 13D/A Beneficial Ownership Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading tm2313192d1_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…